Gender-Affirming Hormone Use in Transgender Individuals: Impact on Behavioral Health and Cognition

por Nguyen, Hillary B., Chavez, Alexis M., Lipner, Emily, Hantsoo, Liisa, Kornfield, Sara L., Davies, Robert D., Epperson, C. Neill
Publicado en Curr Psychiatry Rep (2018)

Subjective Effects, Misuse, and Adverse Effects of Osmotic-Release Methylphenidate Treatment in Adolescent Substance Abusers with Attention-Deficit/Hyperactivity Disorder

por Winhusen, Theresa M., Lewis, Daniel F., Riggs, Paula D., Davies, Robert D., Adler, Lenard A., Sonne, Susan, Somoza, Eugene C.
Publicado 2011

Tetrahydroisoquinoline Phenols: Selective Estrogen Receptor Downregulator Antagonists with Oral Bioavailability in Rat

por Scott, James S., Bailey, Andrew, Davies, Robert D. M., Degorce, Sébastien L., MacFaul, Philip A., Gingell, Helen, Moss, Thomas, Norman, Richard A., Pink, Jennifer H., Rabow, Alfred A., Roberts, Bryan, Smith, Peter D.
Publicado en ACS Med Chem Lett (2015)

Randomized Controlled Trial of Osmotic-Release Methylphenidate with CBT in Adolescents with ADHD and Substance Use Disorders

por Riggs, Paula D., Winhusen, Theresa, Davies, Robert D., Leimberger, Jeffrey D., Mikulich-Gilbertson, Susan, Klein, Constance, Macdonald, Marilyn, Lohman, Michelle, Bailey, Genie L., Haynes, Louise, Jaffee, William B., Hodgkins, Candace, Whitmore, Elizabeth, Trello-Rishel, Kathlene, Tamm, Leanne, Acosta, Michelle C., Royer-Malvestuto, Charlotte, Subramaniam, Geetha, Fishman, Marc, Holmes, Beverly W., Kaye, Mary Elyse, Vargo, Mark A., Woody, George E., Nunes, Edward V., Liu, David
Publicado 2011